FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313485166> ?p ?o ?g. }

• W4313485166 endingPage "e0279981" @default.
• W4313485166 startingPage "e0279981" @default.
• W4313485166 abstract "Androgen deprivation therapy (ADT) is the standard of care in advanced prostate cancer. We conducted a Taiwan National Health Insurance Research Database (NHIRD) study to evaluate the association between ADT and fracture risk in patient with prostate cancer in Taiwan.Between 2001 and 2008, data from the Taiwan NHIRD was collected. We separated newly diagnosed prostate cancer patients into four groups: the injection of gonadotropin-releasing hormone agonists and antagonists group, the orchiectomy group, the oral antiandorgens group and the radical prostatectomy only group. A non-cancer matched control group was also assigned for comparison. T tests, chi-squared tests, multivariate Cox proportional hazard regression were performed. A subsequent fracture event was defined according to the appropriate diagnosis codes (ICD9-CM 800-829) with hospitalization. Patients with fracture before their diagnosis with prostate cancer were excluded.Overall, 22517 newly diagnosed patients with prostate cancer were enrolled in the study. After exclusion criteria were applied, 13321 patients were separated into the injection group (5020 subjects), the orchiectomy group (1193 subjects), the oral group (6059 subjects) and the radical prostatectomy only group (1049 subjects). The mean age of the overall study population was 74.4 years. Multi-variant analysis disclosed a significantly increased risk of fracture in the injection group, the orchiectomy group, and the oral group (hazard ratio [HR] = 1.55, 95%, confidence interval [CI] 1.36 to 1.76, p<0.001, HR = 1.95, 95%, CI 1.61 to 2.37, p<0.001, HR = 1.37, 95%, CI 1.22 to 1.53, p<0.001, respectively). In contrast, a significantly decreased fracture risk was noted in the radical prostatectomy only group (HR = 0.51, 95%, CI 0.35 to 0.74, p = 0.001). Patients receiving osteoporosis medication had a significantly decreased fracture risk (HR = 0.26, 95%, CI 0.19-0.37, p<0.001).ADT is associated with an increased risk of fracture. For patients receiving long-term prostate cancer castration therapy, doctors should always keep this complication in mind and arrange proper monitoring and provide timely osteoporosis medication." @default.
• W4313485166 created "2023-01-06" @default.
• W4313485166 creator A5004447689 @default.
• W4313485166 creator A5021041066 @default.
• W4313485166 creator A5025654001 @default.
• W4313485166 creator A5037179166 @default.
• W4313485166 creator A5037290375 @default.
• W4313485166 creator A5041006089 @default.
• W4313485166 creator A5042850501 @default.
• W4313485166 creator A5087207019 @default.
• W4313485166 creator A5091683814 @default.
• W4313485166 date "2023-01-04" @default.
• W4313485166 modified "2023-10-09" @default.
• W4313485166 title "Conventional androgen deprivation therapy is associated with an increased risk of fracture in advanced prostate cancer, a nationwide population-based study" @default.
• W4313485166 cites W1511220590 @default.
• W4313485166 cites W1997732940 @default.
• W4313485166 cites W1997980871 @default.
• W4313485166 cites W2013136992 @default.
• W4313485166 cites W2041617107 @default.
• W4313485166 cites W2056592226 @default.
• W4313485166 cites W2064222904 @default.
• W4313485166 cites W2066033569 @default.
• W4313485166 cites W2095384504 @default.
• W4313485166 cites W2122906075 @default.
• W4313485166 cites W2161282696 @default.
• W4313485166 cites W2297252729 @default.
• W4313485166 cites W2302688695 @default.
• W4313485166 cites W2584864372 @default.
• W4313485166 cites W261391918 @default.
• W4313485166 cites W2760987813 @default.
• W4313485166 cites W2896276799 @default.
• W4313485166 cites W2990441827 @default.
• W4313485166 cites W3082162960 @default.
• W4313485166 cites W3100599795 @default.
• W4313485166 cites W3113733444 @default.
• W4313485166 cites W3120177091 @default.
• W4313485166 cites W4213176775 @default.
• W4313485166 cites W4220664922 @default.
• W4313485166 cites W4367435927 @default.
• W4313485166 doi "https://doi.org/10.1371/journal.pone.0279981" @default.
• W4313485166 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36598910" @default.
• W4313485166 hasPublicationYear "2023" @default.
• W4313485166 type Work @default.
• W4313485166 citedByCount "8" @default.
• W4313485166 countsByYear W43134851662021 @default.
• W4313485166 countsByYear W43134851662023 @default.
• W4313485166 crossrefType "journal-article" @default.
• W4313485166 hasAuthorship W4313485166A5004447689 @default.
• W4313485166 hasAuthorship W4313485166A5021041066 @default.
• W4313485166 hasAuthorship W4313485166A5025654001 @default.
• W4313485166 hasAuthorship W4313485166A5037179166 @default.
• W4313485166 hasAuthorship W4313485166A5037290375 @default.
• W4313485166 hasAuthorship W4313485166A5041006089 @default.
• W4313485166 hasAuthorship W4313485166A5042850501 @default.
• W4313485166 hasAuthorship W4313485166A5087207019 @default.
• W4313485166 hasAuthorship W4313485166A5091683814 @default.
• W4313485166 hasBestOaLocation W43134851661 @default.
• W4313485166 hasConcept C121608353 @default.
• W4313485166 hasConcept C126322002 @default.
• W4313485166 hasConcept C126894567 @default.
• W4313485166 hasConcept C143998085 @default.
• W4313485166 hasConcept C207103383 @default.
• W4313485166 hasConcept C2777899217 @default.
• W4313485166 hasConcept C2779466945 @default.
• W4313485166 hasConcept C2780192828 @default.
• W4313485166 hasConcept C2781440318 @default.
• W4313485166 hasConcept C2908647359 @default.
• W4313485166 hasConcept C29456083 @default.
• W4313485166 hasConcept C44249647 @default.
• W4313485166 hasConcept C50382708 @default.
• W4313485166 hasConcept C71924100 @default.
• W4313485166 hasConcept C99454951 @default.
• W4313485166 hasConceptScore W4313485166C121608353 @default.
• W4313485166 hasConceptScore W4313485166C126322002 @default.
• W4313485166 hasConceptScore W4313485166C126894567 @default.
• W4313485166 hasConceptScore W4313485166C143998085 @default.
• W4313485166 hasConceptScore W4313485166C207103383 @default.
• W4313485166 hasConceptScore W4313485166C2777899217 @default.
• W4313485166 hasConceptScore W4313485166C2779466945 @default.
• W4313485166 hasConceptScore W4313485166C2780192828 @default.
• W4313485166 hasConceptScore W4313485166C2781440318 @default.
• W4313485166 hasConceptScore W4313485166C2908647359 @default.
• W4313485166 hasConceptScore W4313485166C29456083 @default.
• W4313485166 hasConceptScore W4313485166C44249647 @default.
• W4313485166 hasConceptScore W4313485166C50382708 @default.
• W4313485166 hasConceptScore W4313485166C71924100 @default.
• W4313485166 hasConceptScore W4313485166C99454951 @default.
• W4313485166 hasIssue "1" @default.
• W4313485166 hasLocation W43134851661 @default.
• W4313485166 hasLocation W43134851662 @default.
• W4313485166 hasLocation W43134851663 @default.
• W4313485166 hasOpenAccess W4313485166 @default.
• W4313485166 hasPrimaryLocation W43134851661 @default.
• W4313485166 hasRelatedWork W1998796379 @default.
• W4313485166 hasRelatedWork W2056416825 @default.
• W4313485166 hasRelatedWork W2117050434 @default.
• W4313485166 hasRelatedWork W2118670275 @default.
• W4313485166 hasRelatedWork W2402249956 @default.

• next